City
Epaper

Pinworm medication may treat aggressive skin cancer: Researchers

By IANS | Updated: April 20, 2025 11:22 IST

New York, April 20 A team of US scientists has found that a common pinworm medication may stop ...

Open in App

New York, April 20 A team of US scientists has found that a common pinworm medication may stop and reverse cancer growth in Merkel cell carcinoma, an aggressive form of skin cancer.

The research led by University of Arizona Cancer Center and published in the Journal of Clinical Investigation, found that in laboratory models of Merkel cell carcinoma, pyrvinium pamoate inhibited cancer cell growth and reversed the cancer’s neuroendocrine features.

In mouse models of Merkel cell carcinoma, pyrvinium pamoate reduced tumour growth.

Merkel cell carcinoma is a rare but fast-growing neuroendocrine cancer that is three to five times more likely than melanoma to be deadly. Response rates to current therapies – surgery, radiation and immunotherapy – are limited, resulting in a need for effective and broadly applicable therapeutics.

“Merkel cell carcinoma is increasing in incidence. Even though it’s a rare cancer type, it mimics a lot of properties that other cancers have,” said senior author Megha Padi, assistant professor at the university.

Pyrvinium pamoate, a medication approved by the Food and Drug Administration in 1955 to treat pinworms, has been shown to have antitumour potential in several different cancers, including breast, colorectal, pancreatic and bladder cancers. This is the first time it has been studied in models of Merkel cell carcinoma.

Padi and the research team found that in laboratory models of Merkel cell carcinoma, pyrvinium pamoate inhibited cancer cell growth and reversed the cancer’s neuroendocrine features. In mouse models of Merkel cell carcinoma, pyrvinium pamoate reduced tumor growth.

“This is a hypothesis, but some people think the reason an antiparasitic agent could be effective against cancers is because tumours are a little bit like parasites in our body,” Padi said. “Parasites and tumours must develop ways to use scarce resources in their host to feed themselves and allow for unlimited multiplication. If the pathways that they have hijacked to feed themselves are the same, then you get lucky, and you have a tumour type that could be amenable to killing by these antiparasitic drugs.”

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

CricketShreyas Iyer undergoing treatment at St Vincent's Hospital for spleen injury

InternationalThousands of US flights delayed as government shutdown strains airports

NationalCyclone Montha set to make landfall today, schools closed in Chennai as heavy rain continues

BusinessDespite US tariff challenges, MSMEs show resilience, sectoral indices remain above expansion threshold: SIDBI Survey

NationalMay Chhathi Maiya's blessings always illuminate your lives: PM Modi as festival concludes with rising sun

Technology Realted Stories

TechnologyGovt announces Rashtriya Vigyan Puraskar honouring scientific achievements

TechnologyStrong link between land use and water pollution in Manipur's Loktak Lake catchment: Nagaland varsity study

TechnologyIndia’s electronics sector poised for big leap to large-scale production

TechnologyPIB Fact Check flags AI-manipulated video of Finance Minister promoting fake investment scheme

TechnologyIndia approves 7 ECMS projects worth over Rs 5,500 crore to boost component manufacturing